2026.08.12
Early Consideration for the Revision of Japan’s Regulatory Guidelines on Prototype Vaccines for Pandemic Influenza Preparedness
Introduction to the Early Consideration On July 31, 2026, Japan’s Pharmaceuticals and Medical Devices Agency ( […]